JYLAMVO 2 mg/mL
Methotrexate · SOLUTION · SHORLA ONCOLOGY INC.
No Recall HistoryCurrently in Shortage
Plain English
JYLAMVO is a solution containing methotrexate at 2 mg/mL, taken oral. Manufactured by SHORLA ONCOLOGY INC..
Key Facts
- Brand Name
- JYLAMVO
- Generic Name
- Methotrexate
- NDC Code (Product)
81927-204- Manufacturer
- SHORLA ONCOLOGY INC.
- Strength
- 2 mg/mL
- Dosage Form
- SOLUTION
- Route
- ORAL
- Marketing Status
- Application #
- NDA212479
- Drug Class
- Folate Analog Metabolic Inhibitor [EPC]
- Marketing Start
- 12/15/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is JYLAMVO used for?
JYLAMVO contains Methotrexate. It is a solution taken oral. Consult your doctor for specific uses.
Is JYLAMVO a controlled substance?
JYLAMVO is not classified as a controlled substance by the DEA.
What is the generic name for JYLAMVO?
The generic name for JYLAMVO is Methotrexate. There are 12 other brand versions of Methotrexate.
What is the NDC code for JYLAMVO 2 mg/mL?
The NDC (National Drug Code) for JYLAMVO 2 mg/mL is 81927-204, listed by SHORLA ONCOLOGY INC..